Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 64.75M
March 31, 2026 60.93M
December 31, 2025 51.90M
September 30, 2025 51.31M
June 30, 2025 50.06M
March 31, 2025 49.45M
December 31, 2024 48.34M
September 30, 2024 47.97M
June 30, 2024 47.57M
March 31, 2024 47.06M
December 31, 2023 46.72M
September 30, 2023 46.60M
June 30, 2023 38.22M
March 31, 2023 38.01M
December 31, 2022 36.96M
Date Value
September 30, 2022 36.81M
June 30, 2022 32.69M
March 31, 2022 31.71M
December 31, 2021 30.58M
September 30, 2021 30.41M
June 30, 2021 30.32M
March 31, 2021 30.20M
December 31, 2020 29.78M
September 30, 2020 25.21M
June 30, 2020 25.07M
March 31, 2020 25.03M
December 31, 2019 22.99M
September 30, 2019 22.99M
June 30, 2019 22.99M
March 31, 2019 22.99M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Incyte Corp. 200.98M
Insmed, Inc. 218.28M
Praxis Precision Medicines, Inc. 27.92M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M